Insider filing · CYTK
Sung Lee
EVP, Chief Financial Officer
profile →
Cytokinetics, Incorporated
CYTK · Healthcare · 120 filings in 24 months
ticker →
Sung Lee sold $1.8M of Cytokinetics (CYTK)
Executed May 5, disclosed May 5, the same day.
Value, as filed
$1.8M
23,906 sh × $76.87
Executed
May 5
the trade date, as filed
Disclosed
May 5
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SLSung Lee (EVP, Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $3.2M of CYTK (38,730 sh × $82.30, as filed), executed Jun 24.
The name
CYTKHealthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sung Lee in CYTK
CYTKSALE
Cytokinetics, Incorporated
$266K3,134 sh × $85.00
Exec Jun 29
Filed Jun 29 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated $3.2M
38,730 sh × $82.30
Exec Jun 24
Filed Jun 29 · 5:30 PM ET † CYTKSALE Cytokinetics, Incorporated $307K
4,935 sh × $62.15
Exec Mar 17
Filed Mar 18 · 5:30 PM ET